Cargando…
Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins
Pathogenic fungal diseases in crops are mediated by the release of effector proteins that facilitate infection. Characterising the structure of these fungal effectors is vital to understanding their virulence mechanisms and interactions with their hosts, which is crucial in the breeding of plant cul...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094246/ https://www.ncbi.nlm.nih.gov/pubmed/37047233 http://dx.doi.org/10.3390/ijms24076262 |
_version_ | 1785023793985486848 |
---|---|
author | Rozano, Lina Mukuka, Yvonne M. Hane, James K. Mancera, Ricardo L. |
author_facet | Rozano, Lina Mukuka, Yvonne M. Hane, James K. Mancera, Ricardo L. |
author_sort | Rozano, Lina |
collection | PubMed |
description | Pathogenic fungal diseases in crops are mediated by the release of effector proteins that facilitate infection. Characterising the structure of these fungal effectors is vital to understanding their virulence mechanisms and interactions with their hosts, which is crucial in the breeding of plant cultivars for disease resistance. Several effectors have been identified and validated experimentally; however, their lack of sequence conservation often impedes the identification and prediction of their structure using sequence similarity approaches. Structural similarity has, nonetheless, been observed within fungal effector protein families, creating interest in validating the use of computational methods to predict their tertiary structure from their sequence. We used Rosetta ab initio modelling to predict the structures of members of the ToxA-like and MAX effector families for which experimental structures are known to validate this method. An optimised approach was then used to predict the structures of phenotypically validated effectors lacking known structures. Rosetta was found to successfully predict the structure of fungal effectors in the ToxA-like and MAX families, as well as phenotypically validated but structurally unconfirmed effector sequences. Interestingly, potential new effector structural families were identified on the basis of comparisons with structural homologues and the identification of associated protein domains. |
format | Online Article Text |
id | pubmed-10094246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100942462023-04-13 Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins Rozano, Lina Mukuka, Yvonne M. Hane, James K. Mancera, Ricardo L. Int J Mol Sci Article Pathogenic fungal diseases in crops are mediated by the release of effector proteins that facilitate infection. Characterising the structure of these fungal effectors is vital to understanding their virulence mechanisms and interactions with their hosts, which is crucial in the breeding of plant cultivars for disease resistance. Several effectors have been identified and validated experimentally; however, their lack of sequence conservation often impedes the identification and prediction of their structure using sequence similarity approaches. Structural similarity has, nonetheless, been observed within fungal effector protein families, creating interest in validating the use of computational methods to predict their tertiary structure from their sequence. We used Rosetta ab initio modelling to predict the structures of members of the ToxA-like and MAX effector families for which experimental structures are known to validate this method. An optimised approach was then used to predict the structures of phenotypically validated effectors lacking known structures. Rosetta was found to successfully predict the structure of fungal effectors in the ToxA-like and MAX families, as well as phenotypically validated but structurally unconfirmed effector sequences. Interestingly, potential new effector structural families were identified on the basis of comparisons with structural homologues and the identification of associated protein domains. MDPI 2023-03-26 /pmc/articles/PMC10094246/ /pubmed/37047233 http://dx.doi.org/10.3390/ijms24076262 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rozano, Lina Mukuka, Yvonne M. Hane, James K. Mancera, Ricardo L. Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins |
title | Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins |
title_full | Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins |
title_fullStr | Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins |
title_full_unstemmed | Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins |
title_short | Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins |
title_sort | ab initio modelling of the structure of toxa-like and max fungal effector proteins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094246/ https://www.ncbi.nlm.nih.gov/pubmed/37047233 http://dx.doi.org/10.3390/ijms24076262 |
work_keys_str_mv | AT rozanolina abinitiomodellingofthestructureoftoxalikeandmaxfungaleffectorproteins AT mukukayvonnem abinitiomodellingofthestructureoftoxalikeandmaxfungaleffectorproteins AT hanejamesk abinitiomodellingofthestructureoftoxalikeandmaxfungaleffectorproteins AT manceraricardol abinitiomodellingofthestructureoftoxalikeandmaxfungaleffectorproteins |